Immediate Impact

2 by Nobel laureates 1 from Science/Nature 50 standout
Sub-graph 1 of 25

Citing Papers

Emerging Delivery Systems for Enabling Precision Nucleic Acid Therapeutics
2025 Standout
Hypoxia-tropic delivery of nanozymes targeting transferrin receptor 1 for nasopharyngeal carcinoma radiotherapy sensitization
2025 Standout
2 intermediate papers

Works of Laura Zanaboni being referenced

Plerixafor and G-CSF combination mobilizes hematopoietic stem and progenitors cells with a distinct transcriptional profile and a reduced in vivo homing capacity compared to plerixafor alone
2016
Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload.
2006

Author Peers

Author Last Decade Papers Cites
Laura Zanaboni 536 483 157 25 752
Barry Cooper 427 493 104 25 811
Richard Chapman 378 479 50 31 839
João Ricardo Friedrisch 639 594 181 17 859
Ward D. Noyes 257 339 97 33 813
G. Zanninelli 334 368 56 21 953
Robert Deicher 146 329 47 21 865
Robert T. Breckenridge 224 527 35 36 920
Pornpan Sirankapracha 665 649 107 15 921
K.B. Raja 401 634 44 42 909
Eugenia Prus 515 488 110 27 963

All Works

Loading papers...

Rankless by CCL
2026